P. Zermiani

CA.ME.LI.A. An epidemiological study on the prevalence of CArdiovascular, MEtabolic, LIver and Autoimmune diseases in Northern Italy.

D. Baldassarre, F. Folli, R. Paroni, 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations.

A. Tanaka, K. Kikuchi, H. Ohira, 2009, Journal of hepatology.

Nutrition, Metabolism and Cardiovascular Diseases CA.ME.LI.A. An epidemiological study on the prevalence of cardiovascular, metabolic, liver and autoimmune diseases in Northern Italy --Manuscript

D. Baldassarre, F. Folli, R. Paroni, 2021 .

Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.

C. Raggi, P. Invernizzi, P. Battezzati, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population.

D. Baldassarre, C. Selmi, T. Matthias, 2019, International journal of cardiology.

Antibodies to hepatitis C virus in primary biliary cirrhosis.

P. Battezzati, F. Marelli, M. Podda, 1992, Archives of virology. Supplementum.

A comparison of cholestyramine and diethylaminoethyl-dextran for the treatment of hyperlipidemia and pruritus of primary biliary cirrhosis

L. Ravizza, M. Podda, M. Zuin, 1991 .

P465 SVR IS ASSOCIATED WITH NO RISK REDUCTION OF HCC DEVELOPMENT IN PATIENTS WITH HCV-RELATED CIRRHOSIS. A PROSPECTIVE, UP-TO 23 YEARS, COHORT FOLLOW-UP STUDY

M. Mondelli, P. Maisonneuve, S. Bruno, 2014 .

SVR is associated with no risk reduction of HCC development in patients with HCV-related cirrhosis. A prospective, up-to 23 years, cohort follow-up study

P. Maisonneuve, S. Bruno, S. Rossi, 2014 .

Hepatitis C virus testing in primary biliary cirrhosis.

P. Battezzati, F. Marelli, S. Bruno, 1992, Journal of hepatology.

Lack of association between circulating HCV-RNA and anti-HCV positivity in primary biliary cirrhosis

P. Battezzati, F. Marelli, S. Bruno, 1991, The Lancet.

Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status

P. Invernizzi, P. Battezzati, M. Podda, 1998, Clinical and experimental immunology.

Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study.

V. Vaira, P. Maisonneuve, S. Bruno, 2015, Antiviral research.